Profile: PharmaNetics develops a blood-clotting diagnostic assay called the thrombolytic assessment system. We manufacture and market rapid turnaround diagnostics to assess blood clot formation & dissolution. We offer tests based on proprietary, dry chemistry thrombolytic assessment system for its principal target market of new drug compounds. Our therapeutic diagnostics are used to monitor the effect of antithrombotic agents in the treatment of angina, myocardial infarction, stroke, deep venous thrombosis, pulmonary and arterial emboli.